Domestic and multinational drug corporations on hot struggles for survival.

Published: 2000-01-18 10:00:00

Updated: 2000-01-18 10:00:00

A battle for the pharmaceutical market share between domestic and foreign multinational drug companies has shown a fearful competition for survival, which was more accelerated by a brisk movement of local companies' R&D investment for production of the patented drugs originally developed by fore...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK